Supplementary Info – Biomarker subset analysis of a Phase IIIb, open-label study of afatinib in EGFR TKI-naïve patients with EGFRm+ NSCLC
收藏DataCite Commons2024-02-14 更新2025-04-15 收录
下载链接：
https://future-science-group.figshare.com/articles/dataset/Supplementary_Info_Biomarker_subset_analysis_of_a_Phase_IIIb_open-label_study_of_afatinib_in_EGFR_TKI-na_ve_patients_with_EGFRm_NSCLC/19121837/1
下载链接
链接失效反馈官方服务：
资源简介：
<b>Safety analyses – Methods, </b><b>Safety outcomes</b>
提供机构：
Future Science Group
创建时间：
2022-05-03
